scholarly journals Impact of the efficacy of thrombolytic therapy on the mortality of patients with acute submassive pulmonary embolism: a meta-analysis

2014 ◽  
Vol 12 (7) ◽  
pp. 1086-1095 ◽  
Author(s):  
S. Nakamura ◽  
H. Takano ◽  
Y. Kubota ◽  
K. Asai ◽  
W. Shimizu
2013 ◽  
Vol 84 (1) ◽  
pp. 62 ◽  
Author(s):  
Yun-Ju Cho ◽  
So-My Koo ◽  
Duk Won Bang ◽  
Ki-Up Kim ◽  
Soo-taek Uh ◽  
...  

2016 ◽  
Vol 83 (12) ◽  
pp. 923-932
Author(s):  
Ali Ataya ◽  
Jessica Cope ◽  
Abbas Shahmohammadi ◽  
Hassan Alnuaimat

2003 ◽  
Vol 12 (2) ◽  
pp. 18
Author(s):  
G. Thabut ◽  
D. Thabut ◽  
R.P. Myers

2015 ◽  
Vol 3 (4) ◽  
Author(s):  
Lexin Wang

Pulmonary embolism is a common disease that is associated with significant mobility and mortality. Thrombolysis is potentially life saving when used in conjunction with anticoagulant therapy. Indications for thrombolysis for pulmonary embolism are not well defined. In patients with acute massive pulmonary embolism and hypotension, thrombolytic therapy offers some benefits in terms of mortality reduction. The use of thrombolysis in patients with stable haemodynamics has been controversial for more than two decades. Recent clinical studies have indicated that thrombolytic treatment in conjunction with heparin in patients with submassive pulmonary embolism and normal blood pressure can prevent deterioration of the disease and diminish the need for more intensive therapies during hospitalisation. The role of prehospital thrombolytic therapy for acute pulmonary embolism is unclear and further clinical studies are warranted.


2007 ◽  
Vol 50 (1) ◽  
pp. 78-84 ◽  
Author(s):  
Andrew Worster ◽  
Camala Smith ◽  
Shawna Silver ◽  
Michael D. Brown

2014 ◽  
Vol 36 (10) ◽  
pp. 605-614 ◽  
Author(s):  
Christophe Marti ◽  
Gregor John ◽  
Stavros Konstantinides ◽  
Christophe Combescure ◽  
Olivier Sanchez ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document